SOPHiA GENETICS S.A.

SOPH | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.16

-$0.03 (-0.37%)

Sep 21, 2026, 12:52 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.37%

(1D)

Rating

Updated: Aug 17, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $684.42M

1D Range

8.14 8.33

52W Range

3.21 8.98

Valuation (TTM)

PE -7.12

PB 8.27

EV/EBITDA -9.85

Valuation (NTM)

Forward PE N/A

Forward PEG 0.21

Price Target $11.50

Cash Flow

FCF Yield -6.6%

SBC Adj. FCF Yield -7.9%

SBC Impact -18.9%

Margins

Gross Margin 66.6%

Operating Margin -85.0%

FCF Margin -53.0%

Growth (CAGR)

Revenue 3Y | 5Y 16.8% | 20.3%

Dil EPS 3Y | 5Y -6.0% | 6.8%

FCF 3Y | 5Y 11.4% | 14.9%

Returns

ROA -40.8%

ROE -136.7%

ROIC -48.8%

Financial Health

Net Cash

$59.67M

Current Ratio 2.69

Interest Coverage -11.06

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineer...

Sector Healthcare

Industry Medical - Healthcare Information Services

Employees 415

IPO Date Jul 22, 2021

Website www.sophiagenetics.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 3, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$11.50

Upside

+40.93%

Buy (3)

Hold (0)

Sell (0)

Analyst Details ➞